Sponsor pipeline

Palvella Therapeutics, Inc. clinical trial pipeline

Get alerts when Palvella Therapeutics, Inc.'s trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

Active trials by phase

Phase 2
2
Phase 3
2

Active trials

NCT IDTitleConditionStatusUpdated
Phase 3
NCT05643872 A Study Evaluating the Safety and Pharmacokinetics of QTORIN Rapamycin 3.9% Anhydrous Gel… Pachyonychia Congenita Recruiting 2022-12-09
NCT06239480 SELVA: A Phase 3 Study Evaluating QTORIN 3.9% Rapamycin Anhydrous Gel in the Treatment of… Microcystic Lymphatic Malformation Active, Not Recruiting 2026-03-27
Phase 2
NCT07552077 A Phase 2, Baseline-Controlled Study Evaluating the Safety and Efficacy of PTX-022… Angiokeratomas Recruiting 2026-04-27
NCT06653842 A Phase 2, Baseline-Controlled Study Evaluating the Safety and Efficacy of PTX-022… Cutaneous Venous Malformations Active, Not Recruiting 2026-03-27
Get alerts when Palvella Therapeutics, Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free